Edwards Lifesciences ( EW ) reported EPS of $0.58 in the third quarter of 2012, surpassing the Zacks Consensus Estimate by $0.02. Sales increased 8.5% to $447.9 million, in line with the
Read the article:
Edwards Lifesciences (EW) – Bear of the Day